LONDON, United Kingdom (AFP) — Former world No. 1 Simona Halep has been given a four-year suspension from tennis for two doping offenses, the International Tennis Integrity Agency said Tuesday.

The 31-year-old Romanian has been provisionally suspended since October last year after testing positive for the blood-boosting substance Roxadustat at the 2022 US Open.

And in May, the two-time Grand Slam singles champion was charged with a second anti-doping breach relating to irregularities in her Athlete Biological Passport.

Both charges have been upheld by an independent tribunal.

Halep, who has been provisionally suspended since October 2022, will not be able to play professional tennis again until 6 October 2026.

But soon after the ITIA statement was released, Halep announced she would appeal the decision, saying: "Today (Tuesday), a tribunal under the tennis anti-doping program announced a tentative decision in my case. The last year has been the hardest match of my life, and unfortunately my fight continues."

"I have devoted my life to the beautiful game of tennis. I take the rules that govern our sport very seriously and take pride in the fact I have never knowingly or intentionally used any prohibited substance. I refused to accept their decision of a four-year ban. I intend to appeal to The Court of Arbitration for Sport."

An independent tribunal, which heard evidence from Halep, the winner of the 2018 French Open and 2019 Wimbledon singles titles, met in London on 28 and 29 June.

On 11 September, the tribunal — which also heard evidence from scientific experts and sifted through some 8,000 pages of evidence — confirmed it had found Halep had committed intentional violations under tennis anti-doping program.

One of these was the use of Roxadustat discovered in her urine sample at the 2022 US Open, with the other breach based on collection and analysis of 51 blood samples provided by Halep as part of the ABP program.

Roxadustat is a substance that can be used legitimately to treat anaemia.